ARL2
Basic information
Region (hg38): 11:65014160-65022184
Links
Phenotypes
GenCC
Source:
- microcornea, rod-cone dystrophy, cataract, and posterior staphyloma 1 (Limited), mode of inheritance: AD
- microcornea, rod-cone dystrophy, cataract, and posterior staphyloma 1 (Strong), mode of inheritance: AD
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Microcornea, rod-cone dystrophy, cataract, and posterior staphyloma 1 | AD | General | Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing | Ophthalmologic | 30945270 |
ClinVar
This is a list of variants' phenotypes submitted to
- not_specified (24 variants)
- ARL2-related_condition (1 variants)
- Microcornea,_rod-cone_dystrophy,_cataract,_and_posterior_staphyloma_1 (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the ARL2 gene is commonly pathogenic or not. These statistics are base on transcript: NM_000001667.4. Only rare variants are included in the table.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Effect | PathogenicP | Likely pathogenicLP | VUSVUS | Likely benignLB | BenignB | Sum |
---|---|---|---|---|---|---|
synonymous | 1 | |||||
missense | 22 | 25 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
Total | 1 | 0 | 22 | 3 | 0 |
Highest pathogenic variant AF is 0.0000323865
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
ARL2 | protein_coding | protein_coding | ENST00000246747 | 5 | 8072 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.0214 | 0.914 | 125686 | 0 | 8 | 125694 | 0.0000318 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 1.05 | 82 | 113 | 0.723 | 0.00000722 | 1176 |
Missense in Polyphen | 22 | 42.918 | 0.51261 | 507 | ||
Synonymous | -0.422 | 50 | 46.3 | 1.08 | 0.00000285 | 363 |
Loss of Function | 1.58 | 4 | 9.15 | 0.437 | 4.75e-7 | 97 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.0000634 | 0.0000615 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.000163 | 0.000163 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.0000273 | 0.0000264 |
Middle Eastern | 0.000163 | 0.000163 |
South Asian | 0.0000335 | 0.0000327 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Small GTP-binding protein which cycles between an inactive GDP-bound and an active GTP-bound form, and the rate of cycling is regulated by guanine nucleotide exchange factors (GEF) and GTPase-activating proteins (GAP). GTP-binding protein that does not act as an allosteric activator of the cholera toxin catalytic subunit. Regulates formation of new microtubules and centrosome integrity. Prevents the TBCD-induced microtubule destruction. Participates in association with TBCD, in the disassembly of the apical junction complexes. Antagonizes the effect of TBCD on epithelial cell detachment and tight and adherens junctions disassembly. Together with ARL2, plays a role in the nuclear translocation, retention and transcriptional activity of STAT3. Component of a regulated secretory pathway involved in Ca(2+)-dependent release of acetylcholine. Required for normal progress through the cell cycle. {ECO:0000269|PubMed:10831612, ECO:0000269|PubMed:16525022, ECO:0000269|PubMed:18234692, ECO:0000269|PubMed:18588884, ECO:0000269|PubMed:20740604}.;
- Pathway
- Metabolism of proteins;Metabolism;Regulation of insulin secretion;Protein folding;Post-chaperonin tubulin folding pathway;Integration of energy metabolism
(Consensus)
Intolerance Scores
- loftool
- 0.423
- rvis_EVS
- -0.07
- rvis_percentile_EVS
- 48.12
Haploinsufficiency Scores
- pHI
- 0.333
- hipred
- N
- hipred_score
- 0.213
- ghis
- 0.510
Essentials
- essential_gene_CRISPR
- E
- essential_gene_CRISPR2
- E
- essential_gene_gene_trap
- E
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.926
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | High |
Cancer | High | Medium | High |
Mouse Genome Informatics
- Gene name
- Arl2
- Phenotype
Gene ontology
- Biological process
- tubulin complex assembly;centrosome cycle;positive regulation of cell-substrate adhesion;regulation of microtubule polymerization;positive regulation of microtubule polymerization;negative regulation of GTPase activity;regulation of insulin secretion;maintenance of protein location in nucleus;bicellular tight junction assembly
- Cellular component
- nucleus;nucleolus;mitochondrial intermembrane space;mitochondrial matrix;Golgi apparatus;centrosome;cytosol;focal adhesion;cilium;lateral plasma membrane
- Molecular function
- GTPase activity;GTPase inhibitor activity;protein binding;GTP binding